everolimoosi

Everolimus is a medication used to treat various medical conditions. It belongs to a class of drugs known as mTOR inhibitors. Everolimus works by suppressing the immune system, which is beneficial in preventing organ transplant rejection. It is also used in cancer treatment to slow the growth of tumor cells.

For organ transplantation, everolimus is prescribed to patients who have received a kidney, liver, or heart transplant. By inhibiting the mammalian target of rapamycin (mTOR) pathway, it helps to prevent the body's immune system from attacking the transplanted organ. This reduces the risk of rejection and the need for higher doses of other immunosuppressants.

In oncology, everolimus is used to treat certain types of cancer, including advanced renal cell carcinoma, breast cancer, and pancreatic neuroendocrine tumors. It targets the mTOR pathway, which plays a role in cell growth and division. By blocking this pathway, everolimus can inhibit tumor proliferation and angiogenesis (the formation of new blood vessels that feed tumors).

The administration of everolimus typically involves oral tablets. Like all medications, it can have side effects. Common side effects may include mouth sores, rash, diarrhea, fatigue, and increased susceptibility to infections due to its immunosuppressive properties. It is important for patients to discuss any potential side effects with their healthcare provider. Everolimus may also interact with other medications, so a thorough medical history is crucial.